Schedule 13D ownership disclosure
Intellia Therapeutics Inc
Security class unavailable · CUSIP: 45826J105
Event date: 2021-01-21
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,176,148
- Percent of class
- 3.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-21-006707
- Form type
- SC 13D
- Filer
- Intellia Therapeutics, Inc.
- CIK
- CIK 1652130
- Filed
- Jan 22, 2021
- Reporting period
- Jan 21, 2021
- Description
- Schedule 13D beneficial ownership